Karan Jatwani, MBBS

Karan Jatwani practices at Medical Faculty Associates, Inc in Washington, District of Columbia.

Karan Jatwani's NPI, 1417476649, was assigned on September 19, 2017. Karan Jatwani holds District of Columbia license MD500002694.

Karan Jatwani's primary practice is Medical Faculty Associates, Inc, at 2150 Pennsylvania NW Ave, Washington, DC 20037 in District Of Columbia County. The practice phone is (202) 741-3350.

Karan Jatwani's primary practice is Medical Faculty Associates, Inc in Washington, District of Columbia. Karan Jatwani is also affiliated with The George Washington University Hospital. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Karan Jatwani to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karan Jatwani practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Karan Jatwani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Karan Jatwani is licensed in District of Columbia.

CMS data shows 19 Medicare services from Karan Jatwani across 1 procedure code in 2024, for 26 Medicare patients. Medicare paid $267 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Karan Jatwani in 2024. 73% of them have cancer, and 69% have high blood pressure. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karan Jatwani's median patient age at 74, with 21% women.

In 2024, Karan Jatwani wrote 35 Medicare Part D claims for 16 patients. 66% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $837 in total drug cost.

Karan Jatwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karan Jatwani as offering telehealth.

Dmand AI links 12 papers to Karan Jatwani, published from 2016 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Lung Neoplasms, Arthritis, Psoriatic and Carcinoma, Non-Small-Cell Lung. Karan Jatwani has published most often in Cancers (Basel). Karan Jatwani's most frequent co-authors are Karan Chugh, MD, Shraddha Jatwani, MD and Grace K. Dy, MD.

CMS Open Payments shows 23 general payments to Karan Jatwani from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 87% of the total. Sun Pharmaceutical Industries Inc. paid the most, $268.